Association between Vonoprazan and the risk of gastric cancer after Helicobacter pylori eradication

Potassium-competitive acid blockers (PCABs) have been increasingly used to treat upper gastrointestinal disorders, replacing proton pump inhibitors (PPIs). While PPIs are associated with an increased risk of gastric cancer (GC) after Helicobacter pylori (Hp) eradication, it is uncertain whether PCABs carry the same risk.

https://www.cghjournal.org/article/S1542-3565(24)00165-4/fulltext?rss=yes

Source: Clinical Gastroenterology and Hepatology - February 12, 2024 Category: Gastroenterology Authors: Junya Arai, Atsushi Miyawaki, Tomonori Aoki, Ryota Niikura, Yoku Hayakawa, Hiroaki Fujiwara, Sozaburo Ihara, Mitsuhiro Fujishiro, Masato Kasuga Source Type: research